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Abstract
Background: Pharmacological and genetic studies suggest the importance of the dopaminergic,
serotonergic, and noradrenergic systems in the pathogenesis of Attention Deficit Hyperactivity
Disorder (ADHD) and Disruptive Behavior Disorder (DBD). We have, in a population-based
sample, studied associations between dimensions of the ADHD/DBD phenotype and Monoamine
Oxidase B (MAO-B) activity in platelets and polymorphisms in two serotonergic genes: the
Monoamine Oxidase A Variable Number of Tandem Repeats (MAO-A VNTR) and the 5-
Hydroxytryptamine Transporter gene-Linked Polymorphic Region (5-HTT LPR).
Methods: A population-based sample of twins, with an average age of 16 years, was assessed for
ADHD/DBD with a clinical interview; Kiddie Schedule for Affective Disorders and Schizophrenia
for School-Age Children-Present and Lifetime Version (K-SADS-PL). Blood was drawn from 247
subjects and analyzed for platelet MAO-B activity and polymorphisms in the MAO-A and 5-HTT
genes.
Results: We found an association in girls between low platelet MAO-B activity and symptoms of
Oppositional Defiant Disorder (ODD). In girls, there was also an association between the
heterozygote long/short 5-HTT LPR genotype and symptoms of conduct disorder. Furthermore
the heterozygote 5-HTT LPR genotype in boys was found to be associated with symptoms of
Conduct Disorder (CD). In boys, hemizygosity for the short MAO-A VNTR allele was associated
with disruptive behavior.
Conclusion: Our study suggests that the serotonin system, in addition to the dopamine system,
should be further investigated when studying genetic influences on the development of Disruptive
Behavior Disorders.
Background
Attention Deficit Hyperactivity Disorder (ADHD) and
Disruptive Behavior Disorders (DBD), including Conduct
Disorder (CD) and Oppositional Defiant Disorder
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(ODD), are common child and adolescent psychiatric
diagnoses. They are disabling and associated with high
costs, both for society and in terms of individual suffering.
Research regarding these disorders in children and adoles-
cents from the general population is important in order to
identify risk factors related to the etiology and prognosis
[1]. ADHD affects 3–10% of school aged children [2].
Although the etiology of ADHD is not fully understood, a
strong genetic component in the pathogenesis of the dis-
ease with an estimated heritability of 60–80% has been
reported [1,3]. Consensus estimates suggest that ODD
affects 5–10% of children and that 1–5% meet the diag-
nostic criteria for CD [4]. ADHD is a disorder with two
separate underlying symptom dimensions; a hyperactive-
impulsive dimension, including excessive activity and
impulsive responding, and an inattentive dimension,
including difficulties in sustained attention, distractibil-
ity, disorganization and lack of task persistence. In the
same way DBD includes two dimensions; CD, character-
ized by a variety of persistent antisocial behaviors includ-
ing acts of aggression, destruction of property,
deceitfulness, theft and violation of commonly adhered to
social problems, and ODD, characterized by a sustained
pattern of chronic argumentativeness and anger associ-
ated with compromised social relations with parents and
peers [5].
The symptoms included in the Diagnostic and Statistical
Manual of Mental Disorders, 4th edition (DSM-IV), cate-
gorical diagnoses of ADHD and DBD can also be studied
as dimensions and conceptualized as quantitative varia-
tions of behaviors that most individuals show to a greater
or lesser degree. There is support for an internal validity of
the inattention, hyperactivity/impulsivity, oppositional
defiant, and conduct disorder dimensions respectively [6].
Dimensional measures could distinguish different levels
within the disorder [7].
Molecular, genetic and pharmacological studies have
indicated that the dopaminergic and serotonergic systems
play important roles in the development of ADHD [8]. At
present, polymorphisms in three dopaminergic loci stand
out as the most frequently replicated molecular correlates
of ADHD: DRD4, DRD5, and DAT [9,10]. With regard to
the serotonergic system, there are recent studies reporting
involvement of serotonin in the etiology of ADHD [11].
Serotonergic components are involved in several behavio-
ral traits such as aggression and impulsiveness, which are
frequently associated with ADHD [12,13]. Furthermore,
Gainetdinov et al [14] found that when administering ser-
otonergic drugs together with methylphenidate to mice
lacking the dopamine transporter protein, hyperlocomo-
tor activity was reduced due to increased serotonin levels.
Serotonin and dopamine exert regulatory control over
each other, suggesting that serotonin, in addition to
dopamine, is likely to be linked to ADHD.
Platelet monoamine oxidase (MAO) activity is highly
genetically regulated and has repeatedly been associated
with temperament [15]. Low platelet MAO-B activity cor-
relates with personality traits such as sensation seeking,
impulsivity and monotony avoidance. Platelet MAO-B
has also been associated with deviant behavior such as
type II alcoholism, which is a risk factor in adult ADHD.
MAO-B is considered to be a marker of serotonergic capac-
ity [15] and low activity has previously been associated
with ADHD [16]. Two key genes expressing proteins of
major importance for serotonergic activity are the genes
encoding the serotonin transporter (5-HTT) and the
monoamine oxidase A (MAO-A) enzyme. Both of these
genes have functional promoter polymorphisms that have
been shown to be associated with behavior: the 5-HTT
LPR and the MAO-A VNTR [17,18]. A hypothesis which
currently gains increasing experimental support is that
prenatal serotonin levels are of importance for the devel-
opment of the central serotonergic system. This hypothe-
sis is supported by molecular genetic [19],
pharmacological [20] and brain imaging studies [21].
In the present study, we have tested the hypothesis that a
selection of biological markers, related to central seroton-
ergic functioning, are associated with dimensions of the
ADHD and DBD phenotype. In a population-based series
of adolescent boys and girls, we investigated platelet
MAO-B activity and the candidate genes: MAO-A (VNTR)
and 5-HTT (LPR).
Methods
Study group
The subjects were recruited from the population-based
TCHAD-study [22], and comprised of twins born from
May 1985 to December 1986, living in Stockholm. Of 271
twin pairs, 156 twin pairs i.e. 312 individuals (135 boys
and 177 girls), and at least one parent participated in the
interview procedure. Mean age was 16 years, ranging from
14.6 to 16.7 years. The sample consisted of 17 pairs of
monozygotic boys, 16 pairs of dizygotic boys, 34 pairs of
monozygotic girls, 17 pairs of dizygotic girls, and 72 pairs
of mixed-sex dizygotic twins. Blood sample was obtained
from 247 adolescent individuals (106 boys and 141 girls).
Sixty-seven families refused to participate and 48 families
did not answer by phone and letters. (Fig 1). Four pairs of
twins (8 individuals) were of non-Caucasian origin.
Clinical interview
The twin pairs and parents were invited to an assessment
including a structured clinical interview with Kiddie
Schedule for Affective Disorders and Schizophrenia for
School-Age Children-Present and Lifetime Version (K-BMC Psychiatry 2008, 8:28 http://www.biomedcentral.com/1471-244X/8/28
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SADS-PL). The K-SADS-PL is a widely used semi struc-
tured diagnostic interview designed to assess current and
past episodes of psychopathology in children and adoles-
cent according to Diagnostic and Statistical Manual of
Mental Disorders, 3rd revised edition (DSM-III-R) and
DSM-IV criteria. K-SADS-PL has been shown to be a relia-
ble and valid diagnostic instrument for child and adoles-
cent psychiatric diagnoses [23].
In this study, the present version of the Swedish K-SADS-
PL was used to assess the symptoms according to DSM-IV.
In the K-SADS-PL interview procedure, the interview was
first performed with the child alone and thereafter with at
least one parent. The clinical interviewer then summa-
rized the information from the parent (about the child)
with the information from the child and classified the
symptoms as "not present" (0), "possible" (1) or "certain"
(2).
For the purpose of this study, the symptoms included in
the criteria for ADHD subtypes, ODD and CD were
assessed according to K-SADS-PL and compiled in three
ways:
1. Dimensional scales of the symptoms, that is, the sum-
mary scores of symptoms included in the criteria for the
following diagnoses (scaled 0–2) were calculated: ADHD
inattentive type, ADHD hyperactive type, ADHD com-
bined type, ODD, CD and a combined scale for CD and
ODD.
Sample selection procedure Figure 1
Sample selection procedure.
 
271 twin pairs living in Stockholm area 
156 (312 indivduals) twin pairs 
 accepted a clinical investigation  
and assessment 
 
female =177 male= 135 
Mean age 16 year (14.5 – 17.10) year ) 
115 twin pairs 
 didn’t want to participate (67 families) 
 or didn’t answer letter or 
 phone (48 families) 
Sample of genetic association analyses 
 
female=105   male=92 
247 individuals complete data with blood test 
 
female= 142  male=105 BMC Psychiatry 2008, 8:28 http://www.biomedcentral.com/1471-244X/8/28
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2. DSM-IV diagnostic criteria where applied using the
information from K-SADS-PL. Each symptom was
counted if the item was assessed as "certain" by the inter-
viewer giving the following diagnoses: ADHD inattentive
type, ADHD hyperactive type, ADHD combined type,
ODD, CD and the combination (CD or ODD) (Table 1).
3. The symptoms of the diagnoses described in 1 and 2
were also dichotomized. DSM-IV diagnostic criteria were
applied according to the following; the individual child
was regarded as having "high score of the ADHD pheno-
type" if the symptom was assessed as "possible" or "cer-
tain" using the same diagnostic criteria as in 2. In order to
avoid confusion with clinical diagnoses, we have chosen
to use "high/low scores of phenotype" instead of the term
"sub threshold" or "probable" diagnosis (Table 1).
To study the validity of the high/low dichotomization we
used the Children Global Assessment Scale (CGAS) which
is a scale for children very similar with the Global Assess-
ment of Functioning in DSM-IV [24].
Genotyping and MAO-B activity measurement
Blood samples were obtained from 247 individuals (123
twin pairs and one individual), 106 boys and 141 girls,
and genomic DNA was isolated by standard methods. For
MAO-B activity measurement, platelet rich plasma was
prepared by low-speed centrifugation, 200 × g for 10 min-
utes. Platelet concentration of the plasma samples were
estimated electronically and the plasma was stored at -
80°C.
PCR-based genotyping was performed as described in [25]
(MAO-A VNTR) and [26] (5-HTT LPR). The MAO-A and
5-HTT PCR products were analyzed by electrophoresis on
2% agarose gels and visualized under UV light by ethid-
ium bromide staining. Genotypes were called in two sep-
arate readings.
Because the MAO-A gene is X-linked, only boys were
included in the analysis of the MAO-A VNTR. Girls, hav-
ing two X chromosomes, can be heterozygous and cannot
be functionally characterized with certainty because it is
not possible to know which of the two alleles is inacti-
vated.
Catalytic activity of platelet MAO-B was analyzed with
C14-labelled 2-phenylethylamine (?-PEA) as substrate.
Before analysis, the samples of platelet rich plasma were
thawed and sonicated at 0°C during 5 × 10 seconds with
intervals of 5 seconds for lysis of the platelets. 50 µl of the
plasma was added to 50 µl of 0.1 mM 14C-?-PEA (0.5 µCi/
ml) in 0.1 M sodium phosphate buffer. The reaction mix-
ture was incubated at 37°C for 4 minutes, and the reac-
tion terminated by the addition of 30 µl 1 M HCL.
Thereafter, the radioactive aldehyde product formed was
extracted by shaking for 30 seconds into 750 µl toluene:
ethylacetate (1:1). The samples were then centrifuged at
room temperature for 5 minutes at 1000 × g. The organic
Table 1: Attention-deficit and disruptive behavior disorders derived from Kiddie-SADS – PL interviews in a population-based sample of 
adolescents
Girls Boys Total
Diagnosis n/N* (%) n/N* (%) n/N* (%)
ADHD inattentive 4/174 2.3 4/134 3.0 8/308 2.6
ADHD hyperactive 2/173 1.2 7/134 5.2 9/307 2.9
ADHD combined 0/173 0.0 1/134 0.8 1/307 0.3
ODD 1/173 0.6 2/133 1.5 3/306 1.0
CD 1/174 0.6 1/133 0.8 2/307 0.7
CD or ODD 2/173 1.2 2/133 1.5 4/306 1.3
Girls Boys Total
High dimensions of phenotype** n/N* (%) n/N* (%) n/N* (%)
ADHD inattentive 29/174 16.7 42/134 31.3 71/308 23.1
ADHD hyperactive 21/173 12.1 25/134 18.7 46/307 15,0
ADHD combined 13/173 7.5 16/134 11.9 29/307 9.5
ODD 23/173 13.3 19/133 14.3 42/306 13.7
CD 9/174 5.2 15/133 11.3 24/307 7.8
CD or ODD 25/173 14.5 25/133 18.8 50/306 16.3
*Number of children fulfilling criteria for: diagnosis or high dimensions of phenotype/total number of children
**Dichotomized symptom scale according to possible and certain symptoms (high/low dimensions of phenotype)BMC Psychiatry 2008, 8:28 http://www.biomedcentral.com/1471-244X/8/28
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phase (500 µl), containing the aldehyde product, was
pipetted into vials with 8 ml scintillation fluid and the
amount of radioactive aldehyde product subsequently
quantified by scintillation analysis. Enzyme activity is
expressed as nmol of substrate oxidized per 1010 platelets
per minute. All samples were analyzed blindly and in
duplicate.
Smoking
There are compounds in cigarette smoke that exert inhib-
itory effect on MAO activity, however only in quantities
exceeding 300 cigarettes per month [27]. Information
about cigarette smoking was obtained by asking the sub-
jects, at the time for the blood sampling, whether they had
smoked in the past 24 hours (10% boys, 11% girls). This
information about smoking was used as a covariate in the
statistical analyses of the relationships between behavior
and platelet MAO-B activity. The K-SADS-PL inventory
contains questions about smoking habits as well. We used
smoking more than 2 cigarettes a day as cutoff (11% boys,
12% girls). In order to further explore the possible effects
of smoking on our results, subjects with positive smoking
information from K-SADS-PL were, for the statistical anal-
ysis, combined with the subjects that had been smoking
the past 24 hours before the blood test.
Statistical analyses
Each of the main behavioral symptoms ADHD, ODD and
CD, included either as categorical variables (high/low
scores of ADHD phenotype) or dimensional scales, were
analyzed with respect to their association with MAO-B
activity in platelets and genotype of the MAO-A VNTR and
the 5-HTT LPR. Separate analyses were performed for boys
and girls. For these analyses the general linear model
(GLM) in Stata statistical software package was used [28].
Standard errors were adjusted for clustering within twin
pairs by increasing the estimated standard errors giving
robust estimates of for example p-values. The method is
based on the sandwich or Huber/White variance estima-
tor, a method available in Stata 9.0. The descriptive anal-
ysis of the data presented in the tables includes the entire
sample. However, in the genetic association analyses one
of the children in each pair of the MZ twins was randomly
excluded from the statistical analyses (n = 51). This is
because the MZ twins are supposed to share their genetic
background which makes it somewhat uncertain whether
the adjustment of standard errors, as described above, is
correct for MZ twins.
The dimensional measures of ADHD, ODD and CD prob-
lems had skewed distributions. Therefore, for the dimen-
sional measures, non-parametric bootstrap tests were
performed using the GLM model in Stata. In the GLM
analyses, when calculating the relationships between
behavioral problems and 5-HTT genotype, the nominal
scales included three variants (long-long, long-short,
short-short alleles). This nominal scale was transformed
into three index variables and used in the GLM analyses
using the long-long variant as the reference variable
(omitting this variable). In each of the GLM analyses of
platelet MAO-B activity, the information about cigarette
smoking, at the time for the blood sampling, whether they
had smoked in the past 24 hours, and the smoking infor-
mation from K-SADS-PL were included as a covariate;
smoking (yes/no). For the dimensional ADHD/disruptive
behavior scales interactions between sex and polymor-
phisms in the 5-HTT genotypes were analyzed using GLM.
In the same way interactions between sex and platelet
MAO-B activity were studied.
Children with missing values for two or more symptoms
included in the criteria for each of the diagnoses in this
study (the ADHD subtypes, ODD and CD respectively),
were excluded from the analyses. If there were missing val-
ues for only one of the symptoms in each of the diagnoses
this missing value was recorded as "no symptom."
The study was approved by the ethical committee at Karo-
linska Hospital, Stockholm, Sweden. For all subjects the
participating parent and the teenagers gave written
informed consent.
Results
Prevalence of behavior problems
The observed frequencies of the ADHD phenotype, both
for diagnoses and high/low dimensions of phenotype are
shown in Table 1. Boys reported more ADHD symptoms
than girls. The prevalence of "high scores of ADHD phe-
notype", inattentive type, was 16.7% in girls and 31.3% in
boys; hyperactivity 12.1% in girls and 18.7% in boys; and
the combined type 7.5% in girls and 11.9% in boys. For
ODD symptoms the prevalence of "high scores of ADHD
phenotype" was 13.3% in girls and 14.3% in boys, and for
CD symptoms the prevalence was 5.2% in girls and 11.3%
in boys. Disruptive behavior (ODD or CD) showed a
prevalence of 14.5% in girls and 18.8% in boys.
The CGAS scores were significantly lower (p values from
0.01 to 0.049) in the children with each subtype of the
high dimensions of ADHD phenotype (inattentive, hyper-
activity and combined types) and DBD (ODD, CD and
ODD or CD) compared to children with low dimensions
of the phenotype, supporting the validity of the dichot-
omization.
Platelet MAO-B activity
Platelet MAO-B activity range was 4.0–19.2 nmol/min/
1010 platelets in boys and 6.3–23.7 nmol/min/1010 plate-
lets in girls. Boys had significantly lower mean MAO-B
activity than girls (p < 0.001). Low platelet MAO-B activityBMC Psychiatry 2008, 8:28 http://www.biomedcentral.com/1471-244X/8/28
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was associated with higher levels of ODD symptoms and
disruptive behavior symptoms in girls but not in boys.
This was true for both the DSM-IV dichotomization and
for the dimensional analysis (Table 2 and Additional file
1). There were no statistically significant interactions
between sex and platelet MAO-B activity related to the
dimensional scales of ADHD/disruptive behaviors. Smok-
ing as measured by having smoked the last 24 hours and/
or a positive answer about smoking from the K-SADS-PL
inventory, did not affect MAO-B activity.
MAO-A VNTR in boys
For MAO-A VNTR genotype, 66% of the subjects were
hemizygous for the low activity variant and 33% for the
high activity allele. Boys with the short MAO-A allele were
more likely to show disruptive behavior (p = 0.047) than
boys with the long allele (Additional file 2). No signifi-
cant association was found with regard to the dimen-
sional scales in the sample.
5-HTT LPR
For 5-HTT LPR genotype, 41% carried two copies of the
long allele, 16% carried two copies of the short, and 43%
were heterozygous. The genotype distribution of our sam-
ple did not deviate significantly from Hardy-Weinberg
equilibrium. 5-HTT genotype in boys was found to be
associated with DBD, both using the dimensional scale of
CD symptoms (p = 0.006), ODD or CD (p = 0.018) (Table
3), and also in the dichotomized symptom scale (high/
low dimensions of phenotype) according to DSM-IV (p =
0.045; Additional file 3)
With regard to 5-HTT genotype in girls, the only statisti-
cally significant association was between CD (dimen-
sional scale, p = 0.045) and the long/short genotype
(Additional file 4). There were no associations between 5-
HTT genotype and dichotomized symptom scales.
Discussion
In our population-based sample of adolescent twins, we
observed significant associations between dimensions of
the DBD phenotype and polymorphisms in the candidate
genes 5-HTT and MAO-A, as well as with platelet MAO-B
activity.
The gender ratio in the present study is somewhat lower
than what is usually reported. One explanation for this
could be that our sample consists of adolescents that are
between childhood and adulthood whereas in other stud-
ies subjects are usually children or adults: Meta-analyses
of childhood ADHD have shown a male:female ratio of
3:1 in non referred populations [29]. In our study of ado-
lescents we found 1.6:1 for sub threshold diagnosis
ADHD combined type. Studies of adult ADHD have
shown ratios of 1.6:1 [30] and even 1:1 [31].
Our hypothesis that low platelet MAO-B activity is associ-
ated with high dimensions of the ADHD and DBD pheno-
type was verified only for DBD-symptoms in girls. Acting
out anti-social related behaviors is more common and
more socially acceptable for boys than for girls and behav-
ioral deviances are thought to be under-diagnosed in girls
[32,33]. It is therefore possible that the girls expressing
symptoms in the present study had more severe symp-
toms or more deviant personalities than boys expressing
the same behavior. This explanation is in agreement with
the discussion by Cederblad et al [34]. Another reason for
the relatively lower platelet MAO-B activity in girls with
DBD symptoms could be sex-differences in the K-SADS-
assessment of behavior based on the reports about aggres-
sive behavior from the parents and teenagers. Alterna-
tively, if the behavioral phenotype is assessed in the same
way in boys and girls, without measurement error, there
may be real sex-differences in the association between dis-
ruptive behavior and serotonergic activity.
Compounds in tobacco smoke inhibit the MAO-B
enzyme [35], hence smoking is a confounding factor that
Table 2: Dichotomized symptom scale of ADHD/disruptive behavior and platelet MAO-B activity in girls
MAO-B activity in girls
Dichotomized symptom scale High dimension of phenotype Mean(S.D.) Low dimension of phenotype Mean(S.D.) n/N* p† p‡
ADHD inattentive 12.57(2.40) 13.31(3.53) 22/140 0.381 0.631
ADHD hyperactive 11.99(2.32) 13.32(3.47) 15/139 0.264 0.215
ADHD combined 11.97(1.95) 13.25(3.45) 8/139 0.646 0.291
ODD 11.50(2.18) 13.44(3.46) 18/140 0.033 0.007
CD 11.63(1.48) 13.26(3.42) 6/140 0.227 0.167
ODD or CD 11.52(2.07) 13.47(3.48) 20/140 0.013 0.017
*Number of children with high dimensions of phenotype/total number of children
† Analyses performed using dichotomized symptom scales
‡ Analyses performed using dimensional scalesBMC Psychiatry 2008, 8:28 http://www.biomedcentral.com/1471-244X/8/28
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must be controlled for when measuring platelet MAO-B
activity in humans. There was no difference in MAO activ-
ity between subjects that reported smoking and those that
did not. Snell et al., 2002 reported that platelet MAO
activity was inhibited only after consumption of more
than 10 cigarettes per day and we interpret our result that
none of our young subjects smoked to that degree [27].
Hence, the present results are not explained by smoking as
a confounding factor.
MAO-A VNTR genotype frequencies were in good agree-
ment with those reported by Caspi et al [36]. The 5-HTT
genotype frequencies reported here did not differ from
those of Gorwood et al [37]. Ethnic origin has an impact
on the genotype frequencies in population-based materi-
als, and is a frequent cause of stratification bias. However,
in our sample of adolescents from the Swedish twin regis-
ter, only eight individuals were of non-Caucasian origin.
Traditionally, genes of importance for the serotonergic
system, in particular the 5-HTT and MAO-A genes, have
been associated with certain traits and behavioral disor-
ders [38]. The MAO-A VNTR has been linked to personal-
ity traits such as impulse control and antagonistic
behavior in man [39,40]. Hence we hypothesized that
MAO-A genotype in boys would be associated with sub-
types of ADHD in which aggressive and impulsive behav-
iors are especially prominent. This was indeed found
(Additional file 2). Our findings are in line with those of
Lawson et al [41] who found a correlation between the
short MAO-A allele and conduct disorder in boys with
ADHD. However, there are also studies reporting an asso-
ciation with ADHD related behaviors and the long MAO-
A allele [42], as well as studies in which no association
were found [8]. Further research is needed to elucidate the
direction of gene effects on ADHD related behaviors con-
cerning both the MAO-A and the 5-HTT gene polymor-
phisms.
Also with regard to the 5-HTT polymorphism, there are
conflicting results with studies showing associations
between an ADHD phenotype and both the long and the
short allele as well as no association at all [10,43]. We
found associations between high dimensions of DBD
phenotype and 5-HTT LPR heterozygosity in boys and
girls. Such molecular heterosis at the 5-HTT gene has been
observed in some previous studies where heterozygote
subjects have shown a greater effect for binding capacity
of the 5-HTT as well as for behavioral traits, i.e. social
drinking and depression, than for either of the two
homozygotes [44]. Furthermore, in a recent study, central
5-HTT availability was found to be lowest for hetero-
zygous subjects [45]. Heterosis has also been reported for
other monoamine receptor genes [44]. The heterosis effect
found here points to the importance of conducting analy-
ses on all genotype groups, rather than pooling alleles
together as is frequently done in association studies.
We did not genotype the A/G SNP within the 5-HTT LPR
[46] which may be a limitation of the study. However, the
frequency of this SNP is quite low and the functional
importance of it needs to be further studied [47].
Although the strength of the present study is that inter-
views were carried out by a trained clinician, in contrast to
studies that rely on self-completed questionnaires, there is
still the possibility of false positives, hence, the positive
associations reported here need to be validated in larger
sample sets. Finally, when possible, gene-gene interac-
tions and gene-environment interactions are desirable to
take into consideration when studying behavioral pheno-
types such as ADHD/DBD.
Conclusion
We found a relationship between low platelet MAO-B
activity and ODD, however only in girls. There was, in
girls, also an association between the long/short 5-HTT
genotype and conduct symptoms. Furthermore, the heter-
ozygote 5-HTT genotype in boys was found to be associ-
Table 3: Dimensional symptom scales of ADHD and disruptive behavior related to 5-HTT LPR genotype in boys
5-HTT genotype in boys
Dimensional symptom scale SS short/short n = 12 
Mean(S.D.)
LS long/short n = 47 Mean(S.D.) LL long/long n = 45 Mean(S.D.) p† p‡
ADHD inattentive 4.17(3.10) 6.08(4.25) 4.09(3.73) 0.867 0.122
ADHD hyperactive 3.17(3.43) 4.71(4.00) 3.02(2.97) 0.990 0.089
ADHD combined 7.33(6.05) 10.79(7.04) 7.11(6.43) 0.928 0.064
ODD 1.00(1.48) 2.17(2.82) 1.24(2.05) 0.817 0.079
CD 1.08(1.68) 1.49(2.47) 0.42(1.08) 0.328 0.006
ODD or CD 2.08(2.64) 3.66(4.90) 1.67(2.86) 0.651 0.018
*Total number with the specific genetic marker
†SS and LL compared
‡LS and LL comparedBMC Psychiatry 2008, 8:28 http://www.biomedcentral.com/1471-244X/8/28
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ated with CD. In boys, homozygosity for the short MAO-
A allele was associated with disruptive behavior. Our
study suggests that the serotonin system, in addition to
the dopamine system should be further investigated when
studying genetic influences on the development of Dis-
ruptive Behavior Disorders.
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